Health
UK regulator speeds process to OK coronavirus vaccines for new variants – POLITICO.eu
Oxford/AstraZeneca has said it has begun making a version of its vaccine against a novel variant.
The U.K.s drugs regulator won’t require further large-scale clinical trials to approve modified coronavirus vaccines against new variants, it said on Thursday.
Instead of waiting to see if vaccinated people become infected, as is usually done, the Medicines and Healthcare products Regulatory Agency (MHRA) will require data that show new versions of approved vaccines induce an immune response through blood tests. These studies will be smaller and faster.
The MHRA has developed guidance for the pharmaceutical…
-
Business20 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General18 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News20 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
Noosa News9 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’